Pharmaceuticals
Indian Pharma regulator cuts prices of 43 drug formulations
19 Sep 2014
The price cuts will make formulations used to treat infections and gastro intestinal disorders, a few vaccines, and commonly used antibiotics such as Ciprofloxacin HCl, Cloxacillin and Rifampicin, cheaper by up to 50 per cent
Ranbaxy grilled by US Justice Dept over Medicaid drug pricing
18 Sep 2014
The US Justice Department has requested Ranbaxy for documents and information through a civil investigative demand, though it does not allege any wrongdoing
US judge upholds Ranbaxy-Pfizer Lipitor marketing deal
13 Sep 2014
In a piece of good news for the US FDA-challenged Ranbaxy laboratories, a US court has dismissed an anti-trust suit against Pfizer Inc and India's Ranbaxy that accused them of conspiring to delay sales of generic versions of the cholesterol drug Lipitor
Strong US generic market lifts pharma growth
By By B G Shirsat | 11 Sep 2014
FTC sues AbbVie, Teva over AndroGel delay
09 Sep 2014
.webp)
.webp)
